| Females | Males | p-value |
Subjects n | 312 | 816 | |
Treatment with budesonide | 150 (48) | 408 (50) | 0.56 |
Pack-yrs of smoking | 30 (22–38) | 39 (29–51) | <0.001 |
Age yrs | 52 (47–58) | 53 (48–59) | 0.06 |
FEV1 % predicted | 81.1 (70.2-88.6) | 79.2 (68.3–88.4) | 0.42 |
BMI class <18.5 Kg·m-2 | 17 (5) | 9 (1) | <0.001 |
BMI class 18.5–24.9 Kg·m-2 | 203 (65) | 404 (50) | |
BMI class 25.0–30.0 Kg·m-2 | 75 (24) | 322 (39) | |
BMI class 30.1–43.9 Kg·m-2 | 17 (5) | 81 (10) | |
Phadiatop positive | 30 (10) | 173 (21) | <0.001 |
Wheeze | 185 (59) | 435 (53) | 0.07 |
Dyspnoea | 124 (40) | 290 (36) | 0.19 |
Cough | 185 (59) | 386 (47) | <0.001 |
Phlegm | 112 (36) | 320 (39) | 0.31 |